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ABSTRACT
Background: Gamma interferon (IFN-γ) is produced by
activated natural killer and T cells under pathologic cir-
cumstances. The objective of our study was to compare
the level of IFN-γ in open and endoscopic methods of
vein harvesting for coronary artery bypass surgery
(CABG). 
Method: Ninety samples of human saphenous veins har-
vested from patients prepared for CABG. Pre- and post-
procedure sera of the patients, in addition to super-
natants of 3-day endothelial cell culture, were analyzed
for IFN-γ.
Results: The mean preoperative IFN-γ level (0.09 ± 0.03
pg/mL) and that for postoperative sera (0.08 ± 0.02
pg/mL) were not significantly different (P = 0.2). The
mean IFN-γ level in endothelial cell culture from the
endoscopic (0.18 ± 0.21 pg/mL) and the open method
(0.19 ± 0.39 pg/mL) were not significant (P = 0.89).
Conclusion: We recommend the endoscopic method of
vein harvesting because of its lower morbidity and earli-
er hospital discharge. 
Key Words: IFN-γ, CABG, Endoscopic and open
saphenectomies.
INTRODUCTION
Vascular endothelial cells constitute the interface
between the bloodstream and tissues.1,2 In this strategic
function, endothelial cells (EC) play an active role in all
phases of immunologic and nonimmunologic inflamma-
tion through cytokine networks.3-10
EC produce various cytokines, such as interleukin 1 (IL-
1), interleukin 6 (IL-6), colony stimulating factors (CSF),
and chemotactic factors, and express adhesion mole-
cules.11-14 These data on the function of the endothelial
cells in the immune response were obtained from EC cul-
ture experiments. These experiments found that EC can
also be modulated by interleukins, interferons, and
tumor necrosis factors.15-19
Interferons of all 3 types (α, β, and γ) interact with spe-
cific receptors on virtually all cells of the body, 1 recep-
tor for α and β and another for γ.20 Gamma interferon
(IFN-γ) is a 45-KD homodimeric glycosylated protein
detectably produced only under pathologic circum-
stances (trauma, infection, cancer, and autoimmunity) by
particular lymphocyte populations, namely, activated
natural killer (NK) cells and T cells. IFN-γ suppresses cul-
tured human vascular endothelial cell proliferation,21
induces these cells to express MHC class II antigen,22 and
causes them to change shape and cell organization.23,24 
The impact of trauma on IFN-γ production is our major
concern in saphenous vein preparation for coronary
artery bypass graft (CABG) surgery. The present study
was undertaken to evaluate and compare the levels of
IFN-γ in the endoscopic technique of vein harvesting
with the standard open method, as the new technique is
preferred now in CABG, due to the lower incidence of
postoperative complications.
MATERIALS AND METHODS
The protocols used in this project were reviewed and
approved by the Institutional Review Board of the
Maimonides Medical Center. Patients undergoing coronary
artery bypass graft (CABG) surgery provided informed
consent before enrolling as subjects in this research pro-
tocol. A total of 45 patients were enrolled in the project. 
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Saphenous Vein Harvest
Saphenous vein harvest (SVH) was performed using both
the open and endoscopic techniques on each patient
undergoing elective CABG surgery. Therefore, both an
open technique sample and an endoscopic technique
sample were obtained from each patient enrolled in the
study. Standard endoscopic instrumentation, consisting of
a subcutaneous tissue dissector, a retractor, and a modi-
fied vein stripper, was used for the endoscopic SVH
(Endopath, Ethicon Endosurgery Inc., Cincinnati, OH). In
addition, standard endoscopic equipment including a tel-
evision monitor, light source, and fiberoptic camera with
a 5-mm lens were used.
Prior to the initial skin incision, a preoperative blood
sample was obtained to determine baseline systemic
cytokine levels. The blood sample was immediately cen-
trifuged at 3,000 rpm for 10 minutes at 28°C, and the
supernatants were collected. 
The patient was placed in the “frog-leg” position, and a
3- to 4-cm longitudinal incision was made approximately
4-finger breadth posterior to the patella along the medial
genicular region. The greater saphenous vein (SV) was
identified with the sharp dissecting technique. The por-
tion of the SV dissected below the skin incision was con-
sidered the open technique sample. This segment
remained in place until after adjacent segments were har-
vested with the endoscopic method. Next, a 5-cm sample
was retrieved by dissecting cranially with the endoscopic
technique. This portion of the SV was clipped distally to
identify the direction of blood flow. An additional 5-cm
endoscopic technique sample was obtained by dissecting
below the knee joint. Finally, the portion of the SV
remaining at the site of the open incision was removed
and labeled “open-technique sample.” Significant seg-
ments of the SV remained after collecting samples, and
these were used as the grafts in the CABG surgery. At the
conclusion of SV harvesting, during skin closure, a sec-
ond blood sample was drawn. Vein samples were har-
vested and handled under sterile conditions according to
the operating room protocol at Maimonides Medical
Center. 
Vein Preparation
Vein samples were incubated in 10-mL endothelial cell
culture medium (ECCM) consisting of Iscove’s Modified
Dullbecco’s Medium (IMDM, Fischer Scientific,
Cincinnati, OH) with 200 mL penicillin-streptomycin
solution (Fischer Scientific, Cincinnati, OH) during trans-
port to the laboratory. In the laboratory, each vein sam-
ple was flushed and cannulated. They were then inject-
ed with plasmalyte solution (Baxter Scientific, St. Louis,
MO) containing 60-mg/mL papaverine (Fischer Scientific,
Cincinnati, OH), and the branches were ligated with 3.0
silk sutures. Plasmalyte solution contained sodium 140
mEq/L, potassium 5 mEq/L, magnesium 3 mEq/L, chlo-
ride 98 mEq/L, acetate 27 mEq/L, and gluconate 23
mEq/L. The pH was adjusted to 7.4 by addition of sodi-
um hydroxide, and the final osmolarity was 294 mOsm/Kg.
Endothelial Cell Culture 
Endothelial cell cultures were prepared as described pre-
viously. Vein samples were placed into a culture dish
(Fischer Scientific, Cincinnati, OH) containing 5 mL of
ECCM with the addition of 130 U/mL heparin and 2 mM
L-glutamine. Vein samples were slit open and placed flat
with the luminal surface facing up. The luminal surface
was gently scraped with a sterile scalpel blade, with light
single strokes, covering each area only once. The cells,
which collected on the scalpel blade, were shaken off
into the ECCM in the culture dish. Next, the vein was
rinsed with an aliquot of ECCM, and the rinsing fluid was
added to the culture dish. The ECCM and scraped
endothelial cells in the culture dish was collected and
transferred to a 25 mL culture flask (Fischer Scientific,
Cincinnati, OH). The cells were incubated at 37°C in
humidified room air with 5% CO2 for the next 72 hours.
IFN-γ Measurement
A commercially available enzyme-linked immuno-sor-
bent assay (ELISA) was used to measure the presence of
human IFN-γ (Biosource International, California). IFN-γ
levels were determined in samples of sera and ECCM.
Blood sera were diluted 1:10 in plasmalyte solution
before IFN-γ levels were determined. The ECCM was
aspirated from the cell cultures after 72 hours and dilut-
ed 1:50 in plasmalyte solution. The IFN-γ level was then
determined in the diluted samples.
Statistical Analysis
Results for each group are expressed as mean ± standard
deviation of the quantity of IFN-γ measured in the sam-
ples. Data were analyzed with the two-tailed Student t test. A P-value of less than 0.05 was designated as a sta-
tistically significant difference between groups.
RESULTS
The mean level of IFN-γ for preoperative sera in the 45
patients was 0.096 ± 0.032 pg/mL (mean ± standard devi-
ation) with a confidence interval (CI) = 0.087-0.105, and
that for postoperative sera was 0.089 ± 0.019 pg/mL, with
a confidence interval (CI) = 0.083-0.095. The means were
not statistically significant (P = 0.2). 
The mean level of IFN-γ measured in endothelial cell cul-
ture from the endoscopic technique was 0.185 ± 0.215
with CI = 0.122-0.248, whereas that for the open method
was 0.194 ± 0.39 with CI =0.079-0.308. The difference
between the means of IFN-γ for the 2 techniques was not
statistically significant (P = 0.9) (Figure 1).
DISCUSSION
The autologous greater saphenous vein is considered the
best material for coronary artery revascularization.
However, the morbidity associated with saphenous vein
harvesting is significant with reported wound complica-
tions as high as 43%.25-30
Historically, the greater saphenous vein is exposed and
harvested through a long continuous incision. This inci-
sion may be related to an increase in wound problems;
therefore, there has been much interest in developing a
more closed technique for saphenectomy.27-29 More
recently, a newly developed endoscopic technique for
saphenous vein harvesting has been described with
encouraging results.31-34
Studies of cytokines, leukocytes, and endothelial cell
interaction, and the ensuing biologic events, have
received much attention in recent years.35,36 These stud-
ies found that vascular endothelium can produce several
biologically active compounds, including nitric oxide,
prostacyclin, and various cytokines.30 IFN-γ is a cytokine,
produced by natural killer cells, that plays an important
role in bringing about acute inflammation, mainly
because of the activating effect of IFN-γ on adhesive
properties of endothelial cells and on mediator produc-
tion by mononuclear phagocytes.37
Impairment of the immune response by surgery is sug-
gested by clinical observations of the high rate of infec-
tion seen in postoperative patients. The principal
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immunological deficit after trauma and major surgery is
decreased cell-mediated immunity from an impaired nat-
ural killer (NK) cell response and T helper (Th) 1 lym-
phocyte development. Cell-mediated immunity has been
shown to be depressed for 3 to 10 days postoperatively
in patients who have undergone major surgery.38 In addi-
tion, many studies have shown that IFN-γ is reduced in
the early postoperative phase, reflecting impaired func-
tion of (Th) 1 cells and therefore of cell-mediated
immune response.39
In contrast, our study showed that no significant differ-
ence exists in the level of IFN-γ pre- and postoperative-
ly. We also demonstrated that no significant difference
exists in the level of IFN-γ using both techniques of
saphenous vein harvesting (StdSVH and EndoSVH).
However, the number of patients in most of the other
studies was small, and the measured levels of IFN-γ var-
ied widely. Therefore, conclusions about perioperative
changes of INF-γ are tentative at best. 
The comparable expressions of IFN-γ in the endoscopic
and the traditional technique of vein harvesting suggests
that vein manipulation and minor physical shears would
have a minimal impact on the levels of IFN-γ that may
subsequently affect the performance of the vein conduit.
The limitation of our study is that open saphenectomy
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Figure 1. Graphic presentation of the level of interferon-γ in pre-
operative, postoperative, endoscopic, and open techniques of
saphenous vein harvesting.Significance of Interferon-γ in Coronary Artery Bypass Surgery, Alrawi SJ et al.
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patients undergoing CABG, so we were unable to devise
2 separate groups of patients undergoing each technique
alone.
The method of endothelial cell harvesting and culture
might have falsely affected the level of IFN-γ.
Furthermore, in our study, we stored plasma at -2°C, var-
ious investigators had used different temperatures for
plasma storage in evaluating IFN-γ expression. At the
same time, we have used supernatants of cell culture to
compare endoscopic with the open technique. Other
studies used peripheral blood mononuclear cells to meas-
ure IFN-γ level,40 which might affect our results. Also,
measurement of IFN-γ in blood samples taken 3 to 10
days postoperatively would have incorporated the effect
of CABG itself as a major surgery, and the individual role
of vein harvesting could not be clarified. 
In conclusion, our findings indicate that endoscopic and
open saphenectomies are comparable for IFN-γ expres-
sion in CABG patients. However, we still recommend the
endoscopic method of vein harvesting due to fewer post-
operative leg wound complications compared with tradi-
tional open saphenectomy, which ultimately results in
less postoperative pain, reduced hospital stay, and reduc-
tion in health care costs.41
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